ES8306323A1 - Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa. - Google Patents

Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa.

Info

Publication number
ES8306323A1
ES8306323A1 ES506320A ES506320A ES8306323A1 ES 8306323 A1 ES8306323 A1 ES 8306323A1 ES 506320 A ES506320 A ES 506320A ES 506320 A ES506320 A ES 506320A ES 8306323 A1 ES8306323 A1 ES 8306323A1
Authority
ES
Spain
Prior art keywords
coagulation factor
liposomes
factor viii
protease
enhibidor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES506320A
Other languages
English (en)
Spanish (es)
Other versions
ES506320A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of ES506320A0 publication Critical patent/ES506320A0/es
Publication of ES8306323A1 publication Critical patent/ES8306323A1/es
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES506320A 1980-10-17 1981-10-16 Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa. Expired ES8306323A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55144508A JPS5770814A (en) 1980-10-17 1980-10-17 Oral preparation of blood clotting eighth factor

Publications (2)

Publication Number Publication Date
ES506320A0 ES506320A0 (es) 1983-05-16
ES8306323A1 true ES8306323A1 (es) 1983-05-16

Family

ID=15363986

Family Applications (1)

Application Number Title Priority Date Filing Date
ES506320A Expired ES8306323A1 (es) 1980-10-17 1981-10-16 Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa.

Country Status (5)

Country Link
JP (1) JPS5770814A (da)
DE (1) DE3141223A1 (da)
ES (1) ES8306323A1 (da)
FR (1) FR2492260A1 (da)
GB (1) GB2085729B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536392A (en) * 1983-06-27 1985-08-20 Queen's University At Kingston Method for controlling hemophilia in mammals
IT1164363B (it) * 1983-08-03 1987-04-08 Foscama Biomed Chim Farma Procedimento terapeutico facente uso di liposomi imcorporati fruttosio 1,6 difosfato e procedimento per la preparazione degli stessi
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
FR2581543B1 (fr) * 1985-05-09 1989-07-07 Tressens Dominique Pharmacotechnie permettant la realisation d'une preparation insulinique active par voie orale
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
DE4115453A1 (de) * 1991-05-11 1992-11-12 Knoll Ag Neue wirkstoffkombination
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
FR2706302B1 (fr) * 1993-06-18 1995-08-18 Franche Comte Universite Produit alcalinisant sous forme gastro-résistante.
US6017891A (en) * 1994-05-06 2000-01-25 Baxter Aktiengesellschaft Stable preparation for the treatment of blood coagulation disorders
DE4416166C2 (de) * 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
DE4416180C2 (de) * 1994-05-06 1997-08-14 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen und Verfahren zur Herstellung dieses Präparats
CH689139A5 (de) * 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
AU9221698A (en) * 1997-09-04 1999-03-22 Biozone Laboratories, Inc. Oral liposomal delivery system
EP2921180B1 (en) 1999-02-22 2019-08-14 University of Connecticut Albumin-free factor VIII formulations
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations
DE102009001334B4 (de) 2009-03-04 2017-02-23 Stefan Brosig Einfache magensaftresistente Verkapselung, z.B. von Ingwer und anderen empfindlichen Stoffen
CN109316599A (zh) * 2018-08-24 2019-02-12 上海交通大学医学院附属瑞金医院 一种抑肽酶或其突变体、衍生物、类似物或其组成片段的应用
CN116793783A (zh) * 2023-05-26 2023-09-22 司法鉴定科学研究院 一种胶囊式含药生物基质冻干试剂及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
NL7900459A (nl) * 1979-01-19 1980-07-22 Hendrik Coenraad Hemker Prof D Farmaceutisch preparaat en werkwijze ter bereiding daarvan.

Also Published As

Publication number Publication date
GB2085729A (en) 1982-05-06
JPS5770814A (en) 1982-05-01
FR2492260A1 (fr) 1982-04-23
ES506320A0 (es) 1983-05-16
DE3141223A1 (de) 1982-06-24
FR2492260B1 (da) 1984-07-27
GB2085729B (en) 1984-04-18
JPH03366B2 (da) 1991-01-07

Similar Documents

Publication Publication Date Title
ES8306323A1 (es) Un procedimiento para la preparacion de liposomas con el factor de coagulacion viii y un enhibidor de proteasa.
NO892293D0 (no) Fremgangsmaate for fremstilling av et terapeutisk produkt.
GB9009390D0 (en) Pharmaceutical compositions
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
NL970021I2 (nl) Piperidylesters of -amiden met een alkyleenbrug enfarmaceutische preparaten die deze esters en amiden bevatten.
IE862554L (en) Pharmaceutical compositions
ATE199645T1 (de) Kombination von nekrose-induzierenden substanzen mit substanzen, die durch nekrosen aktiviert werden, zur selektiven therapie von tumoren und entzündlichen erkrankungen
ES544293A0 (es) Un procedimiento para el aislamiento de un gen de relaxina de un ser humano u otro primate o de una especie relacionada
ATE102039T1 (de) Rinderfaktor-xa-hemmender faktor und diesen enthaltende pharmazeutische zusammensetzungen.
ATE122880T1 (de) Mehrfach teilbare tablettenstruktur.
IL103213A (en) Medicaments for treating gastrointestinal disorders containing ranitidine bismuth citrate together with certain helicobacter pylori-inhibiting antibiotics
IS1966B (is) Peptíð p277 hliðstæður og lyfjasamsetningar sem innihalda þær, til meðhöndlunar eða sjúkdómsgreiningar á sykursýki
JPS5234935A (en) Medicinal composition
IT8720771A0 (it) Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
CO5570658A2 (es) Composicion y metodo para el tratamiento de la diabetes
DE69804865D1 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
BR9205642A (pt) Composiçao farmacêutica, compreendo pelo menos uma quinona, e composiçao para fabricaçao de medicamento
CA2120062A1 (en) Use of Sulodexide and of Medicines Containing It in the Treatment of Diabetic Nephropathy
TR199901101T2 (xx) Gastroenstentinal hastal�klar�n tedavisine y�nelik bizmut ve nsaid i�eren bile�imler.
DE3866045D1 (de) Arzneimittel zur behandlung von uraemie.
ES542430A0 (es) Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio.
IL85963A0 (en) Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DE3878154D1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980203